Compare
GMED vs SPY
Up to five stocks or ETFs side by side. Performance is rebased to 100 at the start of the window.
Relative performance
| GMED | SPY | |
|---|---|---|
| Price | $71.05 | $735.29 |
| 1-day | -12.76% | +0.31% |
| YTD | -18.62% | +7.83% |
| 1 year | +15.51% | +8.52% |
| 3 years | +54.49% | +73.97% |
| Market cap | $9.5B | — |
| P/E | 17.5 | — |
| P/S | 3.04 | — |
| P/B | 1.99 | — |
| Revenue growth | +13.40% | — |
| EPS growth | +31.00% | — |
| Gross margin % | 69.1 | — |
| Net margin % | 17.8 | — |
| ROE % | 11.6 | — |
| Debt / equity | 0.00 | — |
| FCF yield % | 8.0 | — |
| Dividend yield % | — | — |
| Beta | 0.83 | 1.00 |
| RSI (14) | 38.7 | 35.1 |
| Technical rating |